Ahmed has an MSc in Pharmacokinetics from Aston University and a BSc in Pharmacology and Physiology from the University of Kent. He is the Research Analyst for the Checkpoint module at Beacon Targeted Therapies. Ahmed has presented at multiple major checkpoint-related conferences including the TIGIT Therapies Summit and the NSCLC Summit to hundreds of people about key trends in checkpoint drug development areas such as clinical trial arms, overall preclinical and clinical trends, drug discontinuations and more. Ahmed has published 20+ digests, landscapes reviews, and infographics pertaining to the checkpoint drug development space.